Vav2tm1.2Geno
Targeted Allele Detail
|
|
| Symbol: |
Vav2tm1.2Geno |
| Name: |
vav guanine nucleotide exchange factor 2; targeted mutation 1.2, Genoway |
| MGI ID: |
MGI:6758213 |
| Synonyms: |
Vav2L332A |
| Gene: |
Vav2 Location: Chr2:27152116-27317045 bp, - strand Genetic Position: Chr2, 19.36 cM
|
| Alliance: |
Vav2tm1.2Geno page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:290809
|
| Parent Cell Line: |
Not Specified (ES Cell)
|
| Strain of Origin: |
Not Specified
|
|
| Allele Type: |
|
Targeted (Not Specified) |
| Mutations: |
|
Insertion, Nucleotide substitutions
|
| |
|
Mutation details: The targeting mutation inserted a lox511 site upstream of the endogenous exon 11 and an FRT-flanked neomycin resistance cassette inserted downstream of exon 11 followed by a floxed and inverted exon 11 with the amino acid substitution of leucine with alanine at position 332 (L332A) and a lox511 site. Flp-mediated recombination removed the FRT-flanked neomycin resistance cassette. Cre-mediated recombination removed the exndogenous exon 11 and reverted the mutated exon 11.
(J:290809)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Vav2 Mutation: |
48 strains or lines available
|
|
| Original: |
J:290809 Lorenzo-Martin LF, et al., Vav2 pharmaco-mimetic mice reveal the therapeutic value and caveats of the catalytic inactivation of a Rho exchange factor. Oncogene. 2020 Jul;39(28):5098-5111 |
| All: |
2 reference(s) |
|